
Redouble AI helps regulated enterprises scale human-in-the-loop GenAI workflows to maintain compliance and oversight while increasing automation. The company builds agentic workflow automation solutions that combine generative AI, human review layers, and advanced software and data engineering to orchestrate tasks and decisioning. It operates as a B2B SaaS/solutions provider serving biopharma, healthcare, insurance, and financial services, and integrates with enterprise data and operational systems. Core technologies include GenAI models, workflow orchestration, human-in-the-loop review mechanisms, and data engineering pipelines. Redouble AI targets regulated markets where audited, compliant AI workflows are required and is used by private and public US organizations.

Redouble AI helps regulated enterprises scale human-in-the-loop GenAI workflows to maintain compliance and oversight while increasing automation. The company builds agentic workflow automation solutions that combine generative AI, human review layers, and advanced software and data engineering to orchestrate tasks and decisioning. It operates as a B2B SaaS/solutions provider serving biopharma, healthcare, insurance, and financial services, and integrates with enterprise data and operational systems. Core technologies include GenAI models, workflow orchestration, human-in-the-loop review mechanisms, and data engineering pipelines. Redouble AI targets regulated markets where audited, compliant AI workflows are required and is used by private and public US organizations.
Company: Redouble AI
Founded: 2024
Focus: Production-grade GenAI workflows with human-in-the-loop for regulated enterprises
Headcount (approx.): 3
Backer: Y Combinator
Regulated enterprise AI deployments requiring compliance, oversight, and auditable human-in-the-loop processes.
2024
Data and Analytics
500000
One round listed
“YC-backed (Y Combinator listed as lead investor)”